Palliative Care Program, Universidad de La Sabana, Chía, Colombia.
Instituto Nacional de Cancerología, Bogotá, Colombia.
J Palliat Med. 2024 Jun;27(6):802-812. doi: 10.1089/jpm.2023.0445. Epub 2024 Feb 13.
Patients with life-limiting illnesses receiving palliative care have a high symptom burden that can be challenging to manage. Guided imagery (GI), a complementary and integrative therapy in which patients are induced to picture mental images with sensory components, has proven in quasi-experimental studies to be effective as a complementary therapy for symptom management. To systematically review randomized controlled trials that report evidence of guided imagery for symptom management in patients with life-limiting illnesses. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline was followed for this review and the search strategy was applied in Medline, CINHAL, and Web of Science. The quality of articles was evaluated using the Cochrane Collaboration's Risk-of-Bias Tool 2 (RoB 2). The results are presented using the Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. A total of 8822 studies were initially identified through the search strategy, but after applying exclusion criteria, 14 randomized controlled trials were included in this review. The quality assessment revealed that four studies had a high risk of bias, nine had some concerns, and one had a low risk of bias. Out of the 14 studies, 6 evaluated oncological diagnosis, while the remaining 8 focused on nononcological diagnoses across 6 different diseases. GI was found to be effective in managing symptoms in 10 out of the 14 studies. Regardless of the disease stage, patients who received guided imagery experienced relief from anxiety, depression, pain, sleep disturbances, and fatigue. GI therapy has shown promising results regarding symptom management in palliative care patients with life-limiting illnesses at different stages.
接受姑息治疗的生命末期疾病患者的症状负担很高,难以控制。引导意象(GI)是一种补充和综合治疗方法,通过该方法可以诱导患者想象具有感官成分的心理意象,已被证明在准实验研究中作为一种补充疗法对症状管理有效。为了系统地回顾报告生命末期疾病患者症状管理中使用引导意象的随机对照试验。本综述遵循系统评价和荟萃分析的首选报告项目(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)指南,并在 Medline、CINHAL 和 Web of Science 中应用了搜索策略。使用 Cochrane 协作风险偏倚评估工具 2(Cochrane Collaboration's Risk-of-Bias Tool 2,RoB 2)评估文章的质量。结果使用系统评价中叙事综合指南呈现。通过搜索策略最初确定了 8822 项研究,但在应用排除标准后,本综述纳入了 14 项随机对照试验。质量评估显示,四项研究存在高偏倚风险,九项研究存在一些问题,一项研究存在低偏倚风险。在这 14 项研究中,有 6 项评估了肿瘤诊断,其余 8 项研究集中在 6 种不同疾病的非肿瘤诊断。14 项研究中有 10 项研究发现 GI 对管理症状有效。无论疾病阶段如何,接受引导意象的患者在焦虑、抑郁、疼痛、睡眠障碍和疲劳方面都得到了缓解。GI 疗法在不同阶段的生命末期姑息治疗患者的症状管理方面显示出了有前景的结果。